Express Scripts, a pharmacy benefits management company based in St. Louis, Mo., late last week disclosed it received an extortion threat in October pertaining to patient records that it holds.

A landmark deal aims to end the pricing games that grossly inflate what you pay at the pharmacy.

Express Scripts was the first to cap out-of-pocket costs for insulin medications at $25 for a 30-day supply in 2019, well before the government took action "The fact is that in the unlikely event the ...